|
1
|
Chen X, Yang L, Oppenheim JJ and Howard
MZ: Cellular pharmacology studies of shikonin derivatives.
Phytother Res. 16:199–209. 2002. View
Article : Google Scholar
|
|
2
|
Gao D, Hiromura M, Yasui H and Sakurai H:
Direct reaction between shikonin and thiols induces apoptosis in
HL60 cells. Biol Pharm Bull. 25:827–832. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yao Y, Brodie AM, Davidson NE, Kensler TW
and Zhou Q: Inhibition of estrogen signaling activates the NRF2
pathway in breast cancer. Breast Cancer Res Treat. 124:585–591.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yingkun N, Lvsong Z and Huimin Y: Shikonin
inhibits the proliferation and induces the apoptosis of human HepG2
cells. Can J Physiol Pharmacol. 88:1138–1146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sankawa U, Ebizuka Y, Miyazaki T, Isomura
Y and Otsuka H: Antitumor activity of shikonin and its derivatives.
Chem Pharm Bull (Tokyo). 25:2392–2395. 1977. View Article : Google Scholar
|
|
6
|
Guo XP, Zhang XY and Zhang SD: Clinical
trial on the effects of shikonin mixture on later stage lung
cancer. Zhong Xi Yi Jie He Za Zhi. 11:598–599. 1991.(In
Chinese).
|
|
7
|
Chen CH, Chern CL, Lin CC, Lu FJ, Shih MK,
Hsieh PY and Liu TZ: Involvement of reactive oxygen species, but
not mitochondrial permeability transition in the apoptotic
induction of human SK-hep-1 hepatoma cells by shikonin. Planta Med.
69:1119–1124. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mao X, Yu CR, Li WH and Li WX: Induction
of apoptosis by shikonin through a ROS/JNK-mediated process in
Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell
Res. 18:879–888. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Z, Wu L, Li L, Tashiro S, Onodera S and
Ikejima T: p53-mediated cell cycle arrest and apoptosis induced by
shikonin via a caspase-9-dependent mechanism in human malignant
melanoma A375-S2 cells. J Pharmacol Sci. 94:166–176. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hisa T, Kimura Y, Takada K, Suzuki F and
Takigawa M: Shikonin, an ingredient of Lithospermum erythrorhizon,
inhibits angiogenesis in vivo and in vitro. Anticancer Res.
18:783–790. 1998.PubMed/NCBI
|
|
11
|
Fujii N, Yamashita Y, Arima Y, Nagashima M
and Nakano H: Induction of topoisomerase II-mediated DNA cleavage
by the plant naphthoquinones plumbagin and shikonin. Antimicrob
Agents Chemother. 36:2589–2594. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ahn BZ, Baik KU, Kweon GR, Lim K and Hwang
BD: Acylshikonin analogues: Synthesis and inhibition of DNA
topoisomerase-I. J Med Chem. 38:1044–1047. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chendil D, Ranga RS, Meigooni D,
Sathishkumar S and Ahmed MM: Curcumin confers radiosensitizing
effect in prostate cancer cell line PC-3. Oncogene. 23:1599–1607.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi HS, Gao X, Li D, et al: A systemic
administration of liposomal curcumin inhibits radiation pneumonitis
and sensitizes lung carcinoma to radiation. Int J Nanomedicine.
7:2601–2611. 2012.PubMed/NCBI
|
|
15
|
Yang Y, Duan W, Liang Z, et al: Curcumin
attenuates endothelial cell oxidative stress injury through Notch
signaling inhibition. Cell Signal. 25:615–629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zoberi I, Bradbury CM, Curry HA, Bisht KS,
Goswami PC, Roti Roti JL and Gius D: Radiosensitizing and
anti-proliferative effects of resveratrol in two human cervical
tumor cell lines. Cancer Lett. 175:165–173. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Papazisis KT, Zambouli D, Kimoundri OT, et
al: Protein tyrosine kinase inhibitor, genistein, enhances
apoptosis and cell cycle arrest in K562 cells treated with
gamma-irradiation. Cancer Lett. 160:107–113. 2000. View Article : Google Scholar
|
|
18
|
Akimoto T, Nonaka T, Ishikawa H, Sakurai
H, Saitoh JI, Takahashi T and Mitsuhashi N: Genistein, a tyrosine
kinase inhibitor, enhanced radiosensitivity in human esophageal
cancer cell lines in vitro: possible involvement of inhibition of
survival signal transduction pathways. Int J Radiat Oncol Biol
Phys. 50:195–201. 2001. View Article : Google Scholar
|
|
19
|
Hillman GG, Forman JD, Kucuk O, et al:
Genistein potentiates the radiation effect on prostate carcinoma
cells. Clin Cancer Res. 7:382–390. 2001.PubMed/NCBI
|
|
20
|
Jung C, Motwani M, Kortmansky J, et al:
The cyclin-dependent kinase inhibitor flavopiridol potentiates
gamma-irradiation-induced apoptosis in colon and gastric cancer
cells. Clin Cancer Res. 9:6052–6601. 2003.
|
|
21
|
Pelicano H, Carney D and Huang P: ROS
stress in cancer cells and therapeutic implications. Drug Resist
Updat. 7:97–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pavlov A, Pirogov A, Trachtenberg A,
Volkova M, Maximov T and Matveeva T: Results of combination
treatment of lung cancer patients: surgery plus radiotherapy and
surgery plus chemotherapy. Cancer Chemother Rep. 4:133–135.
1973.PubMed/NCBI
|
|
23
|
Wiench B, Eichhorn T, Paulsen M and
Efferth T: Shikonin directly targets mitochondria and causes
mitochondrial dysfunction in cancer cells. Evid Based Complement
Alternat Med. 2012:7260252012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen XJ, Wang HB, Ma XQ and Chen JH:
β,β-Dimethylacrylshikonin induces mitochondria dependent apoptosis
through ERK pathway in human gastric cancer SGC-7901 cells. PLoS
One. 7:e417732012.
|
|
25
|
Zhen-Jun S, Yuan-Yuan Z, Ying-Ying F, et
al: β,β-Dimethylacrylshikonin exerts antitumor activity via Notch-1
signaling pathway in vitro and in vivo. Biochem Pharmacol.
84:507–512. 2012.
|
|
26
|
Fan Y, Jin S, He J, Shao Z, Yan J, Feng T
and Li H: Effect of β,β-dimethylacrylshikonin on inhibition of
human colorectal cancer cell growth in vitro and in vivo. Int J Mol
Sci. 13:9184–9193. 2012.
|
|
27
|
Fan Y, Jin S, He J, Shao Z, Yan J, Feng T
and Li H: Effect of β,β-dimethylacrylshikonin on inhibition of
human colorectal cancer cell growth in vitro and in vivo. Int J Mol
Sci. 13:9184–9193. 2012.
|
